ABSTRACT
The incidence of keratinocyte cancer (basal cell and squamous cell carcinomas of the skin) is 17-fold lower in Singapore than the UK1-3, despite Singapore receiving 2-3 times more ultraviolet (UV) radiation4,5. Aging skin contains somatic mutant clones from which such cancers develop6,7. We hypothesized that differences in keratinocyte cancer incidence may be reflected in the normal skin mutational landscape. Here we show that, compared to Singapore, aging facial skin from populations in the UK has a fourfold greater mutational burden, a predominant UV mutational signature, increased copy number aberrations and increased mutant TP53 selection. These features are shared by keratinocyte cancers from high-incidence and low-incidence populations8-13. In Singaporean skin, most mutations result from cell-intrinsic processes; mutant NOTCH1 and NOTCH2 are more strongly selected than in the UK. Aging skin in a high-incidence country has multiple features convergent with cancer that are not found in a low-risk country. These differences may reflect germline variation in UV-protective genes.
Subject(s)
Carcinoma, Squamous Cell , Skin Neoplasms , Humans , Skin Neoplasms/genetics , Skin Neoplasms/pathology , Carcinoma, Squamous Cell/genetics , Keratinocytes , Ultraviolet Rays/adverse effects , MutationABSTRACT
Neural stem cells (NSCs) are self-renewing multipotent cells that undergo symmetric and asymmetric cell division during development of the nervous system. The behavior of NSCs is tightly regulated by intrinsic processes such as transcriptional and post-transcriptional control, as well as the stem cell niche factors that activate ligand-receptor-mediated signaling pathways. However, the role of these niche factors that regulate NSC behavior is not clearly understood. We identified chondroitin sulfate proteoglycan, apolipoprotein E (ApoE) and cystatin C as factors derived from the mouse neurosphere conditioned medium. Here, we show that ApoE is an autocrine/paracrine factor that regulates NSC survival. Stimulation of NSC survival is mediated by ApoE receptor interaction and the downstream extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway. In addition, ApoE also enhanced neurosphere formation of mouse embryonic stem cell-derived NSCs. Finally, in vitro differentiation studies with ApoE knock-out NSCs suggest a role for ApoE in oligodendrogenesis.
Subject(s)
Apolipoproteins E/pharmacology , Mitogen-Activated Protein Kinase Kinases/metabolism , Neural Stem Cells/drug effects , Neural Stem Cells/metabolism , Signal Transduction/physiology , Animals , Apolipoproteins E/deficiency , Cell Differentiation/drug effects , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Dose-Response Relationship, Drug , Embryo, Mammalian , Enzyme Inhibitors/pharmacology , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/physiology , Humans , Low Density Lipoprotein Receptor-Related Protein-1/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Oligodendroglia/physiology , Prosencephalon/cytology , Protein Binding/drug effects , Signal Transduction/drug effectsABSTRACT
Neural stem cells (NSCs) have the ability to self-renew and generate the three major neural lineages - astrocytes, neurons and oligodendrocytes. NSCs and neural progenitors (NPs) are commonly cultured in vitro as neurospheres. This protocol describes in detail how to determine the NSC frequency in a given cell population under clonal conditions. The protocol begins with the seeding of the cells at a density that allows for the generation of clonal neurospheres. The neurospheres are then transferred to chambered coverslips and differentiated under clonal conditions in conditioned medium, which maximizes the differentiation potential of the neurospheres. Finally, the NSC frequency is calculated based on neurosphere formation and multipotency capabilities. Utilities of this protocol include the evaluation of candidate NSC markers, purification of NSCs, and the ability to distinguish NSCs from NPs. This method takes 13 days to perform, which is much shorter than current methods to enumerate NSC frequency.
Subject(s)
Clone Cells , Neural Stem Cells , Astrocytes , Cell Differentiation , Cells, Cultured , Humans , Neurons , Oligodendroglia , Stem CellsABSTRACT
Hepatocellular carcinoma (HCC) is associated with high mortality and the current therapy for advanced HCC, Sorafenib, offers limited survival benefits. Here we assessed whether combining the TLR3 agonist: lysine-stabilized polyinosinic-polycytidylic-acid (poly-ICLC) with Sorafenib could enhance tumor control in HCC. Combinatorial therapy with poly-ICLC and Sorafenib increased apoptosis and reduced proliferation of HCC cell lines in vitro, in association with impaired phosphorylation of AKT, MEK and ERK. In vivo, the combinatorial treatment enhanced control of tumor growth in two mouse models: one transplanted with Hepa 1-6 cells, and the other with liver tumors induced using the Sleeping beauty transposon. Tumor cell apoptosis and host immune responses in the tumor microenvironment were enhanced. Particularly, the activation of local NK cells, T cells, macrophages and dendritic cells was enhanced. Decreased expression of the inhibitory signaling molecules PD-1 and PD-L1 was observed in tumor-infiltrating CD8+ T cells and tumor cells, respectively. Tumor infiltration by monocytic-myeloid derived suppressor cells (Mo-MDSC) was also reduced indicating the reversion of the immunosuppressive tumor microenvironment. Our data demonstrated that the combinatorial therapy with poly-ICLC and Sorafenib enhances tumor control and local immune response hence providing a rationale for future clinical studies.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carboxymethylcellulose Sodium/analogs & derivatives , Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Niacinamide/analogs & derivatives , Phenylurea Compounds/administration & dosage , Poly I-C/chemistry , Polylysine/analogs & derivatives , Toll-Like Receptor 3/agonists , Animals , Apoptosis , CD8-Positive T-Lymphocytes/cytology , Carboxymethylcellulose Sodium/chemistry , Cell Line, Tumor , Cell Proliferation , Cell Survival , Disease Progression , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Immune System , Immunosuppressive Agents/chemistry , MAP Kinase Kinase Kinases/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Inbred NOD , Mice, SCID , Niacinamide/administration & dosage , Niacinamide/chemistry , Phenylurea Compounds/chemistry , Phosphorylation , Polylysine/chemistry , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction , SorafenibABSTRACT
Surgical resection of tumors is often followed by regrowth at the primary site and metastases may emerge rapidly following removal of the primary tumor. Macrophages are important drivers of tumor growth, and here we investigated their involvement in postoperative relapse as well as explore macrophage depletion as an adjuvant to surgical resection. RETAAD mice develop spontaneous metastatic melanoma that begins in the eye. Removal of the eyes as early as 1 week of age did not prevent the development of metastases; rather, surgery led to increased proliferation of tumor cells locally and in distant metastases. Surgery-induced increase in tumor cell proliferation correlated with increased macrophage density within the tumor. Moreover, macrophages stimulate tumor sphere formation from tumor cells of post-surgical but not control mice. Macrophage depletion with a diet containing the CSF-1R specific kinase inhibitor Ki20227 following surgery significantly reduced postoperative tumor recurrence and abrogated enhanced metastatic outgrowth. Our results confirm that tumor cells disseminate early, and show that macrophages contribute both to post-surgical tumor relapse and growth of metastases, likely through stimulating a population of tumor-initiating cells. Thus macrophage depletion warrants exploration as an adjuvant to surgical resection.
Subject(s)
Macrophages/pathology , Melanoma, Experimental/pathology , Melanoma, Experimental/surgery , Animals , Cell Growth Processes/physiology , Cell Line, Tumor , Disease Models, Animal , Female , Humans , Macrophages/metabolism , Male , Melanoma, Experimental/metabolism , Mice , Mice, Transgenic , Neoplasm Recurrence, Local/prevention & control , Proto-Oncogene Proteins c-ret/genetics , Surgical Procedures, Operative/methodsABSTRACT
The infiltration of T lymphocytes within tumors is associated with better outcomes in cancer patients, yet current understanding of factors that influence T-lymphocyte infiltration into tumors remains incomplete. In our study, Temozolomide (TMZ), a chemotherapeutic drug used to treat metastatic melanoma, induced T-cell infiltration into transplanted melanoma and into genitourinary (GU) tumors in mice developing spontaneous melanoma. In contrast, TMZ treatment did not increase T-cell infiltration into cutaneous tumors, despite similar increases in the expression of the (C-X-C) chemokines CXCL9 and CXCL10 in all sites after TMZ exposure. Our findings reveal that the matrix architecture of the GU tumor stroma, and its ability to present CXCL9 and CXCL10 after TMZ treatment played a key role in favouring T-cell infiltration. We subsequently demonstrate that modifications of these key elements by combined collagenase and TMZ treatment induced T-cell infiltration into skin tumors. T cells accumulating within GU tumors after TMZ treatment exhibited T helper type-1 effector and cytolytic functional phenotypes, which are important for control of tumor growth. Our findings highlight the importance of the interaction between tumor stroma and chemokines in influencing T-cell migration into tumors, thereby impacting immune control of tumor growth. This knowledge will aid the development of strategies to promote T-cell infiltration into cancerous lesions and has the potential to markedly improve treatment outcomes.
ABSTRACT
Resection of infiltrated tumor-draining lymph nodes (TDLNs) is a standard practice for the treatment of several cancers including breast cancer and melanoma. However, many randomized prospective trials have failed to show convincing clinical benefits associated with LN removal and the role of TDLNs in cancer dissemination is poorly understood. Here, we found in a well-characterized spontaneous mouse model of uveal melanoma that the growth of the primary tumor was accompanied by increased lymphangiogenesis and cancer cell colonization in the LNs draining the eyes. But, unexpectedly, early resection of the TDLNs increased the growth of the primary tumor and associated blood vessels as well as promoted cancer cell survival and dissemination. These effects were accompanied by increased tumor cell proliferation and expression of phosphorylated AKT. Topical application of a broad anti-inflammatory agent, Tobradex, or an oral treatment with cyclooxygenase-2 specific inhibitor, Celecoxib, reversed tumor progression observed after complete lymphadenectomy. Our study confirms the importance of tumor homeostasis in cancer progression by showing the enhancing effects of TDLN removal on tumor growth and cancer cell dissemination, and suggests that TDLN resection may only be beneficial if used in combination with anti-inflammatory drugs such as Tobradex and Celecoxib.
Subject(s)
Cell Movement , Cell Proliferation , Lymph Node Excision/adverse effects , Melanoma/surgery , Neoplasms, Experimental/surgery , Uveal Neoplasms/surgery , Animals , Cell Movement/drug effects , Cell Proliferation/drug effects , Cyclooxygenase 2 Inhibitors/pharmacology , Disease Progression , Female , Genetic Predisposition to Disease , Humans , Male , Melanoma/genetics , Melanoma/metabolism , Melanoma/secondary , Mice , Mice, Transgenic , Neoplasms, Experimental/genetics , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/pathology , Neovascularization, Pathologic , Phenotype , Phosphorylation , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-ret/genetics , Time Factors , Tumor Burden , Uveal Neoplasms/genetics , Uveal Neoplasms/metabolism , Uveal Neoplasms/pathology , Vascular Endothelial Growth Factor A/metabolism , Vascular Endothelial Growth Factor Receptor-1/metabolismABSTRACT
Neuregulins (NRG) play important roles in the development, maintenance, and repair of the nervous system, with influences on neuronal migration, synaptogenesis, receptor subunit composition, and the proliferation/survival of oligodendrocytes and Schwann cells. However, the precise detail of how the NRGs signal through ErbB receptors, particularly at central synapses, is incomplete. The receptor kinase domain provides sites for association with adaptor proteins. In addition, evidence from recent reports suggests that ErbB2/4 receptors, through their C-terminal amino acids, can form specific associations with scaffolding proteins. The existence of such assemblies expands the range of signaling cascades available to the NRGs.
Subject(s)
Central Nervous System/physiology , ErbB Receptors/physiology , Nerve Tissue Proteins/physiology , Neuregulins/physiology , Receptor, ErbB-2/physiology , Adaptor Proteins, Signal Transducing , Animals , Carrier Proteins/physiology , Humans , Intracellular Signaling Peptides and Proteins , Mice , Mice, Knockout , Mice, Neurologic Mutants , Nerve Tissue Proteins/chemistry , Neuregulins/genetics , Nitric Oxide/physiology , Nitric Oxide Synthase/physiology , Nitric Oxide Synthase Type II , Protein Structure, Tertiary , Receptor, ErbB-2/chemistry , Receptor, ErbB-3/physiology , Receptor, ErbB-4 , Schwann Cells/metabolism , Synapses/physiologyABSTRACT
M2 macrophages promote tumor growth and metastasis, but their interactions with specific tumor cell populations are poorly characterized. Using a mouse model of spontaneous melanoma, we showed that CD34- but not CD34+ tumor-initiating cells (TICs) depend on M2 macrophages for survival and proliferation. Tumor-associated macrophages (TAMs) and macrophage-conditioned media protected CD34- TICs from chemotherapy in vitro. In vivo, while inhibition of CD115 suppressed the macrophage-dependent CD34- TIC population, chemotherapy accelerated its development. The ability of TICs to respond to TAMs was acquired during melanoma progression and immediately preceded a surge in metastatic outgrowth. TAM-derived transforming growth factor-ß (TGFß) and polyamines produced via the Arginase pathway were critical for stimulation of TICs and synergized to promote their growth.
Subject(s)
Arginase/metabolism , Macrophages/immunology , Melanoma/immunology , Melanoma/metabolism , Neoplastic Stem Cells/immunology , Transforming Growth Factor beta/metabolism , Animals , Cell Proliferation/physiology , Cell Survival/physiology , Disease Models, Animal , Female , Male , Melanoma/pathology , Mice , Mice, Mutant Strains , Neoplastic Stem Cells/metabolism , Neoplastic Stem Cells/pathology , Signal Transduction/immunologyABSTRACT
The immune system has multiple, complex, and sometimes opposing roles during cancer progression. While immune-compromised individuals have a higher incidence of cancers, inflammation is also associated with increased risk of disease progression. It is becoming apparent that simple measures of immune responses in the blood are of limited use in cancer. Instead, the importance of the exact identity and functional characteristics of tumor-infiltrating immune cells is increasingly recognized. This realization has led to recent studies that have revealed a critical role for chemokine expression in the tumor microenvironment and suggested a therapeutic potential of manipulating intratumoral expression of chemokines to alter the local immune milieu.
Subject(s)
Biomarkers, Tumor/immunology , Chemokines/immunology , Neoplasms/diagnosis , Neoplasms/immunology , Animals , Cell Movement/immunology , Disease Models, Animal , Disease Progression , Gene Expression Regulation, Neoplastic , Humans , Immunity , Immunologic Surveillance , Mice , Mice, Transgenic , Neoplasms/genetics , Prognosis , Tumor MicroenvironmentSubject(s)
Immunotherapy/methods , Macrophages/immunology , Melanoma/therapy , Tumor Escape , Tumor Microenvironment , Uveal Neoplasms/therapy , Animals , Cell Communication , Humans , Macrophages/metabolism , Melanoma/immunology , Melanoma/metabolism , Melanoma/pathology , Phenotype , Signal Transduction , Uveal Neoplasms/immunology , Uveal Neoplasms/metabolism , Uveal Neoplasms/pathologyABSTRACT
Understanding how autocrine/paracrine factors regulate neural stem cell (NSC) survival and growth is fundamental to the utilization of these cells for therapeutic applications and as cellular models for the brain. In vitro, NSCs can be propagated along with neural progenitors (NPs) as neurospheres (nsphs). The nsph conditioned medium (nsph-CM) contains cell-secreted factors that can regulate NSC behavior. However, the identity and exact function of these factors within the nsph-CM has remained elusive. We analyzed the nsph-CM by mass spectrometry and identified DSD-1-proteoglycan, a chondroitin sulfate proteoglycan (CSPG), apolipoprotein E (ApoE) and cystatin C as components of the nsph-CM. Using clonal assays we show that CSPG and ApoE are responsible for the ability of the nsph-CM to stimulate nsph formation whereas cystatin C is not involved. Clonal nsphs generated in the presence of CSPG show more than four-fold increase in NSCs. Thus CSPG specifically enhances the survival of NSCs. CSPG also stimulates the survival of embryonic stem cell (ESC)-derived NSCs, and thus may be involved in the developmental transition of ESCs to NSCs. In addition to its role in NSC survival, CSPG maintains the three dimensional structure of nsphs. Lastly, CSPG's effects on NSC survival may be mediated by enhanced signaling via EGFR, JAK/STAT3 and PI3K/Akt pathways.
Subject(s)
Chondroitin Sulfate Proteoglycans/metabolism , ErbB Receptors/metabolism , Neurons/cytology , Stem Cells/cytology , Animals , Apolipoproteins E/metabolism , Cell Proliferation , Cell Survival , Culture Media, Conditioned/pharmacology , Cystatin C/metabolism , Embryonic Stem Cells/cytology , Immunohistochemistry/methods , Mice , Mice, Inbred C57BL , Neural Stem Cells/cytology , Phosphatidylinositol 3-Kinases/metabolism , Signal TransductionABSTRACT
The central nervous system (CNS) is a large network of interconnecting and intercommunicating cells that form functional circuits. Disease and injury of the CNS are prominent features of the healthcare landscape. There is an urgent unmet need to generate therapeutic solutions for CNS disease/injury. To increase our understanding of the CNS we need to generate cellular models that are experimentally tractable. Neural stem cells (NSCs), cells that generate the CNS during embryonic development, have been identified and propagated in vitro. To develop NSCs as a cellular model for the CNS we need to understand more about their genetics and cell biology. In particular, we need to define the mechanisms of self-renewal, proliferation and differentiation--i.e. NSC behavior. The analysis of pluripotency of embryonic stem cells through mapping regulatory networks of transcription factors has proven to be a powerful approach to understanding embryonic development. Here, we discuss the role of transcription factors in NSC behavior.